Navigation Links
The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008
Date:8/18/2008

Quarterly Reports use Market Intelligence and Competitive Analysis from Thomson Reuters to Explore Various Aspects of the Pharmaceutical Pipeline

LONDON and PHILADELPHIA, Aug. 18 /PRNewswire/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, has announced the availability of the Pharma Matters reports covering the time period January-March 2008. Launched more than two years ago, the quarterly Pharma Matters reports cover all aspects of the pharmaceutical pipeline, leveraging strategic intelligence and competitive analysis from Thomson Pharma(R), Newport Horizon Premium(TM) and the Thomson Messaging Mapping System(SM).

The Ones to Watch -- A Thomson Reuters quarterly review of the latest phase changes in the pharmaceutical pipeline, this report is based on the strategic data and analysis from Thomson Pharma, the world's leading pharmaceutical competitive intelligence solution. In the report covering Q1 2008, the top five most promising drugs launched or receiving approval were:

DRUG DISEASE COMPANY

Intelence(TM) HIV-1 infection Tibotec

Pristiq(TM) Depression Wyeth

Ionsys(TM) Acute pain ALZA

Arcalyst(TM) CIAS1-associated Regeneron

periodic syndromes

Moxatag(TM) Streptococcus MiddleBrook

pyogenes-associated

pharyngitis, tonsillitis

More analysis, as well as information on drugs entering clinical Phases I, II and III, are available in the full report: http://scientific.thomsonreuters.com/thomsonpharma/media/pdfs/tpqr/totw_jan -march_08.pdf

(Due to the length of this URL, it may be necessa
'/>"/>

SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Thomson Scientific Predicts Nobel Laureates
3. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
4. Thomson Scientific Announces BONDplus for Biological Researchers
5. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
6. International Society of Hair Restoration Surgery Hosts 15th Annual Scientific Meeting in Las Vegas, September 26-30, 2007
7. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
8. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
9. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
10. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
11. Delta Dental Plans Association Forms National Scientific Advisory Committee

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...to consider change after 30-minute psychosocial in... 27 (HealthDay News) -- A program that gets persis...p their dangerous behavior may lead to significant... , The new study included 184 men and women wit...who were randomly assigned to one of two intervent...
(Date:11/27/2009)...RNewswire/ - Uploadable USB pedometers may be new,.... A combination of advanced accelerometer function... term concern over the accuracy of self-reported d...ard improved participation in a fitness program. ,...ellness suppliers to integrate this technology. "O...
(Date:11/27/2009)...27 Preventing disease i...nately every year, new vaccines are being added to... boost immunity for the same period of time? And, ... to keep immunity strong? ,, In this month,s ...cademy of Pediatrics, Michael Pichichero MD, Direc...
(Date:11/27/2009)...ion vehicles may reduce future disease burden, res...Day News) -- Encouraging city dwellers to walk and...eater public health benefits than increased used o...nd. , The study compared the projected health e... scenarios for London, England, and Delhi, India: ...
(Date:11/27/2009)...rpose bilingual coloring books designed for childr...community to educate - inform parents and children... to Dinosuars to ABC,S and a host of other topics....) November 27, 2009 -- Today’s children have...busy any hour of the day, but one of the oldest an...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...Health Minister Dr Anbumani Ramadoss, in an attemp...ese Encephalitis has left for Beijing to approach ...able in a sizeable // quantity. The heavy toll of ...iled discussions with the Chinese minister for Nat...
...Doctors say they want to investigate the case of a...of the virus, reports BBC. // Two Sunday news...in London, was diagnosed as HIV-positive in 2002, ... tests. Stimpson did not take any medication for H...
...Study results showed that people who lived longer ... social position. The research study was carried o...d's School of Public Health who reported their fin...ildren’s with a score more than 130 are considered...
...John Cacioppo and researchers have found that the ...d it runs in to families making it a genetic chara...le should join a group which has more social chara...nd they found that loneliness is not related to he...
...A new study appearing in the November 1, 2005 issu...that a new gene profile may help in predicting how...nd to aggressive chemotherapy. // In many patie...nce of chemotherapy-resistant cancer cells, most p...
...In a breakthrough, which could eventually lead to ...he HIV virus, scientists from the US National Canc...ving in the human body to produce chemicals that b... bacteria. The researchers have successfully...
Other Medicine News:Health News:Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations 2Health News:British man 'Recovered from HIV' 2Health News:Genetic Profile To Predict Ovarian Cancer Prognosis 2Health News:Genetically modified bacteria to combat HIV 2
(Date:11/27/2009)... ACUO TECHNOLOGIES, developers of h... data migration tools and services, is pleased to ...rk Office has approved a patent application for an...work." Acuo Technologies is pleased to add the U.S.... In general, the granted patent application broad...
(Date:11/25/2009)...5 Heska Corporation ( HS...iagnostic and specialty products to the veterinary...iagnostics Corporation for the supply of blood gas...inary market. ,, (Logo: http://www.newscom...a and Roche share the same passion for innovating ...
(Date:11/25/2009)...wswire/ -- BioTrends Research Group, Inc. released...eport, the first in a multi-phase syndicated marke... Ortho-Biotech,s Stelara, from product launch thro...ve of the report provides quantitative information...ormation from a subset of 20. The reports assess ...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2FDA Issues Guidance for Derma Sciences Exclusive Wound Dressing With pDADMAC 60241 1FDA Issues Guidance for Derma Sciences Exclusive Wound Dressing With pDADMAC 60241 2FDA Issues Guidance for Derma Sciences Exclusive Wound Dressing With pDADMAC 60241 3FDA Issues Guidance for Derma Sciences Exclusive Wound Dressing With pDADMAC 60241 4Dr Ken Dychtwald to Discuss Looming Caregiver Crunch and the Importance of Proactive Long Term Care Planning 60239 1Dr Ken Dychtwald to Discuss Looming Caregiver Crunch and the Importance of Proactive Long Term Care Planning 60239 2Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 1Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 2Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 3Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 4Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 5Pittsburgh Partners Launch Promising Family Centered Care Model 3A Special Focus on Promoting Parental Well Being and Healthy Child Development 60237 6
...y 21 Romark Laboratories, L.C., a,privately-owned...mpletion,of enrollment into its Phase II clinical ...oxanide in combination with standard of care thera...ype 1 who have previously,failed to respond to the...irin). The company expects to announce interim dat...
...rgentina, May 21 Today at the,World Congress of C...w,Perspectives in Atrial Fibrillation Management" ...ogy, St George,s University of London,highlighted ...cal trial,results, as the way forward in the futur...on form of cardiac arrhythmia., To view the Multi...
Other Medicine Technology:Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 2Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6
syngoDynamics
... Magnetic Navigation System™, the worlds fir...h digital flat panel detectors in both planes, whi...ccuracy of catheter-based procedures to facilitate...tional medicine. The new technology features a bip...
...d of imaging applications possibilities, from univ...rocedures. A veritable workhorse for all occasions...oductivity of your department., System highlight...d "room-mobile design , Broad applications spect...
AXIOM Artis BC
Medicine Products: